Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China
· Delayed Price · Currency is CNY 110.55
-0.28 (-0.25%)
Apr 29, 2026, 3:00 PM CST
Beijing Hotgen Biotech Revenue
In the year 2025, Beijing Hotgen Biotech had annual revenue of 404.88M CNY, down -20.75%. Beijing Hotgen Biotech had revenue of 95.17M in the quarter ending December 31, 2025, a decrease of -23.01%.
Revenue
404.88M
Revenue Growth
-20.58%
P/S Ratio
24.32
Revenue / Employee
n/a
Employees
850
Market Cap
9.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 404.88M | -106.02M | -20.75% |
| Dec 31, 2024 | 510.90M | -36.94M | -6.74% |
| Dec 31, 2023 | 547.84M | -3.01B | -84.60% |
| Dec 31, 2022 | 3.56B | -1.81B | -33.76% |
| Dec 31, 2021 | 5.37B | 4.86B | 945.54% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Liaoning Chengda Biotechnology | 1.39B |
| Aurisco Pharmaceutical | 1.68B |
| Bio-Thera Solutions | 935.22M |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 1.94B |
| Shanghai Medicilon | 1.16B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 1.84B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 15.90B |
| HitGen | 525.57M |